Tamoxifen is a drug that is used to treat breast cancer. It inhibits the activities of the estrogen receptor in breast epithelial cells, which are the cells that are relevant to breast cancer. One of the concerns that scientists had during the development of Tamoxifen as a therapy for breast cancer was that other cell types require estrogen signaling for their function. For example, it is known that cells in bone tissue require estrogen signaling. As a result, there was a concern that use of Tamoxifen would lead to bone loss in patients. In reality, however, researchers were surprised to find that Tamoxifen actually led to an increase in bone density in breast cancer patients. At the same time, Tamoxifen did inhibit the activity of the estrogen receptor in breast epithelial cells in these patients. What is the best explanation for this finding?
A) The estrogen receptor is bound to different coactivators in different tissues.
B) Tamoxifen binds different parts of the estrogen receptor in different tissues.
C) Tamoxifen can only enter certain cell types.
D) Bone cells make use of a different type of estrogen receptor that does not bind to Tamoxifen.
Correct Answer:
Verified
Q1: A researcher is working to generate a
Q2: Leptin is a circulating hormone that is
Q3: Vasopressin is a hormone that is primarily
Q4: You have identified a molecule, molecule X,
Q5: You are interested in developing an inhibitor
Q7: You are having lunch with an elderly
Q8: What is the mechanism by which binding
Q9: How are receptor tyrosine kinases and steroid
Q10: Some cancers are caused by the overexpression
Q11: Your research project involves the characterization of
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents